To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

A Swedish national post-m… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.

Journal article
Authors Carolina Holmén
Fredrik Piehl
Jan Hillert
Anna Fogdell-Hahn
Malin Lundkvist
Elin Karlberg
Petra Nilsson
Charlotte Dahle
Nils Feltelius
Anders Svenningsson
Jan Lycke
Tomas Olsson
Published in Multiple sclerosis (Houndmills, Basingstoke, England)
Volume 17
Issue 6
Pages 708-19
ISSN 1477-0970
Publication year 2011
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Pages 708-19
Language en
Links dx.doi.org/10.1177/1352458510394701
Subject categories Medical and Health Sciences

Abstract

A post marketing surveillance study was conducted to evaluate safety and efficacy of natalizumab in Swedish multiple sclerosis (MS) patients since its introduction in August 2006 until March 2010.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?